ASPR Announces New DPA Funding For API Supply Chain

By Sigi Ris / November 25, 2024 at 5:12 PM
The Administration Strategic Preparedness and Response (ASPR) announced two new investments in domestic production of active pharmaceutical ingredients (API) in the United States under the Defense Production Act Monday (Nov. 25), which it says will aim to rebuild and protect the U.S. public health supply chain as an essential part of national defense. ASPR’s Office of Industrial Base Management and Supply Chain will provide a $32.4 million investment to Manus Bio, Inc in Massachusetts. The funds will go toward expanding...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.